Trial Profile
Carbetocin at Elective Cesarean Deliveries: A Non-inferiority Study Between 20 and 100 Micrograms - Part 4
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Carbetocin (Primary)
- Indications Postpartum haemorrhage
- Focus Therapeutic Use
- 26 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Oct 2014 New trial record